JSPR

Jasper Therapeutics, Inc.

20.27 USD
+0.03 (+0.15%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Jasper Therapeutics, Inc. stock is up 73.25% since 30 days ago. The next earnings date is Mar 11, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 60% of the previous 4 February’s closed higher than January. In the last 1 Unusual Options Trades, there were 1 PUT.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
06 Feb 20:09 19 Jul, 2024 12.50 PUT 120 0

About Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering. The company is based in Redwood City, California.